Issue Date: June 2, 2014 | Web Date: May 30, 2014
Pfizer Drops Pursuit Of AstraZeneca
Pfizer ended its attempt to take over AstraZeneca last week after the British firm rejected its final $119 billion offer. “We continue to believe that our final proposal was compelling and represented full value,” Pfizer CEO Ian C. Read said.
In turning down the U.S. company’s bid, AstraZeneca Chairman Leif Johansson declined to heed some shareholders who wanted him to at least engage in talks. Rather, Johansson said he preferred to . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society